{
  "instance_id": 226,
  "chat_eval": "1",
  "answer": "PDGFRB",
  "extracted_solution_or_last_step": "# Causal Gene Identification for Ovarian Neoplasms GWAS Locus\n\n## Analysis Summary\n\nI conducted a comprehensive analysis to identify the most likely causal gene for ovarian neoplasms from the provided locus containing 18 genes: ARSI, CAMK2A, CD74, CDX1, CSF1R, HMGXB3, MYOZ3, NDST1, PDE6A, PDGFRB, PPARGC1B, RBM22, RPS14, SLC26A2, SLC6A7, SYNPO, TCOF1, and TIGD6.\n\n## Key Findings\n\n### Primary Candidates Identified\n\n**CSF1R (Colony Stimulating Factor 1 Receptor)**\n- Found in 4 ovarian cancer/neoplasm gene lists in DisGeNET [1]\n- Appears in OMIM for ovarian cancer susceptibility\n- Associated with epithelial ovarian cancer, ovarian carcinoma, and stage IV ovarian carcinoma\n\n**PDGFRB (Platelet-Derived Growth Factor Receptor Beta)**\n- Found in 2 ovarian cancer gene lists in DisGeNET [1]\n- Appears in OMIM for ovarian cancer susceptibility\n- Strong functional evidence for ovarian cancer involvement [2]\n\n### Supporting Evidence\n\n**Database Associations:**\n- CSF1R showed consistent appearances across multiple ovarian cancer-related phenotypes in DisGeNET\n- PDGFRB appeared in ovarian carcinoma and ovarian neoplasm gene lists\n\n**Literature Evidence:**\n- PDGFRB demonstrated direct functional relevance to ovarian cancer progression through:\n  - Stromal PDGFR-beta expression as a prognostic factor in high-grade serous ovarian cancer patients [3]\n  - Facilitation of ovarian cancer cell proliferation, invasion, and migration via the PDGFRB/PI3K/AKT signaling pathway [4]\n  - Inclusion in comprehensive genomic profiling studies of ovarian leiomyosarcoma [5]\n\n**Functional Pathways:**\n- PDGFRB is involved in critical cancer progression pathways including PI3K/AKT signaling, which regulates cell proliferation and survival\n- CSF1R is involved in immune cell regulation and cancer-related inflammation\n\n## Conclusion\n\n**PDGFRB** is identified as the most likely causal gene for ovarian neoplasms based on the convergence of multiple lines of evidence including database associations, functional pathway involvement, and direct literature support for its role in ovarian cancer progression.\n\n## References\n\n[1] Gene-disease associations from DisGeNET database analysis  \n[2] OMIM database: ovarian cancer susceptibility gene associations  \n[3] J Cancer Res Clin Oncol. 2024: Stromal PDGFR-beta expression as prognostic factor in high-grade serous ovarian cancer  \n[4] J Transl Med. 2023: TMEM119 facilitates ovarian cancer progression via PDGFRB/PI3K/AKT pathway  \n[5] Int J Gynecol Cancer. 2024: Genomic profiling of primary ovarian leiomyosarcoma",
  "error": null,
  "last_200_tokens": "in DisGeNET - PDGFRB appeared in ovarian carcinoma and ovarian neoplasm gene lists **Literature Evidence:** - PDGFRB demonstrated direct functional relevance to ovarian cancer progression through: - Stromal PDGFR-beta expression as a prognostic factor in high-grade serous ovarian cancer patients [3] - Facilitation of ovarian cancer cell proliferation, invasion, and migration via the PDGFRB/PI3K/AKT signaling pathway [4] - Inclusion in comprehensive genomic profiling studies of ovarian leiomyosarcoma [5] **Functional Pathways:** - PDGFRB is involved in critical cancer progression pathways including PI3K/AKT signaling, which regulates cell proliferation and survival - CSF1R is involved in immune cell regulation and cancer-related inflammation ## Conclusion **PDGFRB** is identified as the most likely causal gene for ovarian neoplasms based on the convergence of multiple lines of evidence including database associations, functional pathway involvement, and direct literature support for its role in ovarian cancer progression. ## References [1] Gene-disease associations from DisGeNET database analysis [2] OMIM database: ovarian cancer susceptibility gene associations [3] J Cancer Res Clin Oncol. 2024: Stromal PDGFR-beta expression as prognostic factor in high-grade serous ovarian cancer [4] J Transl Med. 2023: TMEM119 facilitates ovarian cancer progression via PDGFRB/PI3K/AKT pathway [5] Int J Gynecol Cancer. 2024: Genomic profiling of primary ovarian leiomyosarcoma </solution>",
  "answer_count_in_last_200_tokens": 6,
  "potential_answer_with_has_is": "PDGFRB",
  "potential_answer_final_answer": null,
  "potential_answer_conclusion": "PDGFRB",
  "potential_answer_emerges": null,
  "count_potential_answer_with_has_is": 8,
  "count_potential_answer_final_answer": 0,
  "count_potential_answer_conclusion": 8,
  "count_potential_answer_emerges": 0,
  "prompt": "Your task is to identify likely causal genes within a locus for a given GWAS phenotype. From the list, provide only the likely causal gene (matching one of the given genes). \nIdentify the causal gene.\nGWAS phenotype: Ovarian Neoplasms\nGenes in locus: {ARSI},{CAMK2A},{CD74},{CDX1},{CSF1R},{HMGXB3},{MYOZ3},{NDST1},{PDE6A},{PDGFRB},{PPARGC1B},{RBM22},{RPS14},{SLC26A2},{SLC6A7},{SYNPO},{TCOF1},{TIGD6}\n",
  "task_name": "gwas_causal_gene_pharmaprojects",
  "execution_time": 2718.061057329178
}